These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 15087241

  • 1. Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2004 Apr 12; 489(3):187-91. PubMed ID: 15087241
    [Abstract] [Full Text] [Related]

  • 2. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 3. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2005 Jun 15; 516(3):219-26. PubMed ID: 15963494
    [Abstract] [Full Text] [Related]

  • 4. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
    Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Kato A, Koyama T.
    Eur J Pharmacol; 2005 Sep 27; 520(1-3):37-42. PubMed ID: 16153636
    [Abstract] [Full Text] [Related]

  • 5. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
    Page ME, Lucki I.
    Neuropsychopharmacology; 2002 Aug 27; 27(2):237-47. PubMed ID: 12093597
    [Abstract] [Full Text] [Related]

  • 6. In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.
    Ortega JE, Fernández-Pastor B, Callado LF, Meana JJ.
    Eur Neuropsychopharmacol; 2010 Nov 27; 20(11):813-22. PubMed ID: 20813509
    [Abstract] [Full Text] [Related]

  • 7. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
    Linnér L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH.
    J Pharmacol Exp Ther; 2001 May 27; 297(2):540-6. PubMed ID: 11303041
    [Abstract] [Full Text] [Related]

  • 8. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P, Flore G, Pira L, Longu G, Gessa GL.
    Eur J Pharmacol; 2004 Mar 08; 487(1-3):105-11. PubMed ID: 15033381
    [Abstract] [Full Text] [Related]

  • 10. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
    Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R.
    Br J Pharmacol; 2003 Aug 08; 139(7):1281-8. PubMed ID: 12890707
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
    Invernizzi RW, Parini S, Sacchetti G, Fracasso C, Caccia S, Annoni K, Samanin R.
    Br J Pharmacol; 2001 Jan 08; 132(1):183-8. PubMed ID: 11156576
    [Abstract] [Full Text] [Related]

  • 12. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
    Nakamura S, Ago Y, Itoh S, Koyama Y, Baba A, Matsuda T.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):95-8. PubMed ID: 16321379
    [Abstract] [Full Text] [Related]

  • 13. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G.
    Neurochem Int; 2011 Jan 28; 58(1):78-84. PubMed ID: 21056607
    [Abstract] [Full Text] [Related]

  • 14. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A, Gobert A, Iob L, Cistarelli L, Melon C, Millan MJ.
    Psychopharmacology (Berl); 2001 Nov 28; 158(2):213-8. PubMed ID: 11702096
    [Abstract] [Full Text] [Related]

  • 15. The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
    Mizoguchi N, Saigusa T, Aono Y, Sekino R, Takada K, Oi Y, Ueda K, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):94-8. PubMed ID: 18996113
    [Abstract] [Full Text] [Related]

  • 16. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
    Valentini V, Cacciapaglia F, Frau R, Di Chiara G.
    J Neurochem; 2006 Jul 28; 98(1):113-21. PubMed ID: 16805801
    [Abstract] [Full Text] [Related]

  • 17. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
    Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R.
    Br J Pharmacol; 1999 Nov 28; 128(6):1332-8. PubMed ID: 10578149
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.
    Br J Pharmacol; 2004 Jun 28; 142(3):469-78. PubMed ID: 15148253
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.
    Hudson AL, Lalies MD, Silverstone P.
    Can J Physiol Pharmacol; 2012 Jun 28; 90(6):803-9. PubMed ID: 22512539
    [Abstract] [Full Text] [Related]

  • 20. Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.
    Parini S, Renoldi G, Battaglia A, Invernizzi RW.
    Neuropsychopharmacology; 2005 Jun 28; 30(6):1048-55. PubMed ID: 15668723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.